ArticleMolecular therapy : the journal of the American Society of Gene Therapy2021

Ligand-activated RXFP1 gene therapy ameliorates pressure overload-induced cardiac dysfunction.

Nuttarak Sasipong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.